Selected research
Market Structure
Global Biodegradable Medical Polymer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Biodegradable Medical Polymer market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Biodegradable Medical Polymer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biodegradable Medical Polymer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biodegradable Medical Polymer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Biodegradable Medical Polymer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Biodegradable Medical Polymer include Poly-Med, PCAS, Mitsui Chemicals, KLS Martin, Evonik, DSM and Corbion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Biodegradable Medical Polymer market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biodegradable Medical Polymer and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biodegradable Medical Polymer sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biodegradable Medical Polymer market size, projected growth trends, production technologies, key applications, and end-use industries.
Biodegradable Medical Polymer Segment by Company
Poly-Med
PCAS
Mitsui Chemicals
KLS Martin
Evonik
DSM
Corbion
Biodegradable Medical Polymer Segment by Type
Polysaccharides
Polycaprolactone (PCL)
Polylactic Acid (PLA)
PLGA
Polyglycolic Acid (PGA)
Biodegradable Medical Polymer Segment by Application
Drug Delivery
Orthopedics
Others
Biodegradable Medical Polymer Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Medical Polymer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Medical Polymer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Medical Polymer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Biodegradable Medical Polymer market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biodegradable Medical Polymer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biodegradable Medical Polymer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Biodegradable Medical Polymer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Polysaccharides
- Polycaprolactone (PCL)
- Polylactic Acid (PLA)
- PLGA
- Polyglycolic Acid (PGA)
Applications
- Drug Delivery
- Orthopedics
- Others
Companies covered
- Poly-Med
- PCAS
- Mitsui Chemicals
- KLS Martin
- Evonik
- DSM
- Corbion
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Biodegradable Medical Polymer Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Biodegradable Medical Polymer Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Biodegradable Medical Polymer Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Biodegradable Medical Polymer Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Biodegradable Medical Polymer Market Dynamics
- 2.1 Biodegradable Medical Polymer Industry Trends
- 2.2 Biodegradable Medical Polymer Industry Drivers
- 2.3 Biodegradable Medical Polymer Industry Opportunities and Challenges
- 2.4 Biodegradable Medical Polymer Industry Restraints
3 Biodegradable Medical Polymer Market by Manufacturers
- 3.1 Global Biodegradable Medical Polymer Revenue by Manufacturers (2021-2026)
- 3.2 Global Biodegradable Medical Polymer Sales by Manufacturers (2021-2026)
- 3.3 Global Biodegradable Medical Polymer Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Biodegradable Medical Polymer Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Biodegradable Medical Polymer Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Biodegradable Medical Polymer Manufacturers, Product Type & Application
- 3.7 Global Biodegradable Medical Polymer Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Biodegradable Medical Polymer Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Biodegradable Medical Polymer Players Market Share by Revenue in 2025
- 3.8.3 2025 Biodegradable Medical Polymer Tier 1, Tier 2, and Tier 3
4 Biodegradable Medical Polymer Market by Type
- 4.1 Biodegradable Medical Polymer Type Introduction
- 4.1.1 Polysaccharides
- 4.1.2 Polycaprolactone (PCL)
- 4.1.3 Polylactic Acid (PLA)
- 4.1.4 PLGA
- 4.1.5 Polyglycolic Acid (PGA)
- 4.2 Global Biodegradable Medical Polymer Sales by Type
- 4.2.1 Global Biodegradable Medical Polymer Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biodegradable Medical Polymer Sales by Type (2021-2032)
- 4.2.3 Global Biodegradable Medical Polymer Sales Market Share by Type (2021-2032)
- 4.3 Global Biodegradable Medical Polymer Revenue by Type
- 4.3.1 Global Biodegradable Medical Polymer Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Biodegradable Medical Polymer Revenue by Type (2021-2032)
- 4.3.3 Global Biodegradable Medical Polymer Revenue Market Share by Type (2021-2032)
5 Biodegradable Medical Polymer Market by Application
- 5.1 Biodegradable Medical Polymer Application Introduction
- 5.1.1 Drug Delivery
- 5.1.2 Orthopedics
- 5.1.3 Others
- 5.2 Global Biodegradable Medical Polymer Sales by Application
- 5.2.1 Global Biodegradable Medical Polymer Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biodegradable Medical Polymer Sales by Application (2021-2032)
- 5.2.3 Global Biodegradable Medical Polymer Sales Market Share by Application (2021-2032)
- 5.3 Global Biodegradable Medical Polymer Revenue by Application
- 5.3.1 Global Biodegradable Medical Polymer Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Biodegradable Medical Polymer Revenue by Application (2021-2032)
- 5.3.3 Global Biodegradable Medical Polymer Revenue Market Share by Application (2021-2032)
6 Global Biodegradable Medical Polymer Sales by Region
- 6.1 Global Biodegradable Medical Polymer Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biodegradable Medical Polymer Sales by Region (2021-2032)
- 6.2.1 Global Biodegradable Medical Polymer Sales by Region (2021-2026)
- 6.2.2 Global Biodegradable Medical Polymer Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Biodegradable Medical Polymer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Biodegradable Medical Polymer Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Biodegradable Medical Polymer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Biodegradable Medical Polymer Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Biodegradable Medical Polymer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Biodegradable Medical Polymer Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Biodegradable Medical Polymer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Biodegradable Medical Polymer Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Biodegradable Medical Polymer Revenue by Region
- 7.1 Global Biodegradable Medical Polymer Revenue by Region
- 7.1.1 Global Biodegradable Medical Polymer Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Biodegradable Medical Polymer Revenue by Region (2021-2026)
- 7.1.3 Global Biodegradable Medical Polymer Revenue by Region (2027-2032)
- 7.1.4 Global Biodegradable Medical Polymer Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Biodegradable Medical Polymer Revenue (2021-2032)
- 7.2.2 North America Biodegradable Medical Polymer Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Biodegradable Medical Polymer Revenue (2021-2032)
- 7.3.2 Europe Biodegradable Medical Polymer Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Biodegradable Medical Polymer Revenue (2021-2032)
- 7.4.2 Asia-Pacific Biodegradable Medical Polymer Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Biodegradable Medical Polymer Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Biodegradable Medical Polymer Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Poly-Med
- 8.1.1 Poly-Med Company Information
- 8.1.2 Poly-Med Business Overview
- 8.1.3 Poly-Med Biodegradable Medical Polymer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Poly-Med Biodegradable Medical Polymer Product Portfolio
- 8.1.5 Poly-Med Recent Developments
- 8.2 PCAS
- 8.2.1 PCAS Company Information
- 8.2.2 PCAS Business Overview
- 8.2.3 PCAS Biodegradable Medical Polymer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 PCAS Biodegradable Medical Polymer Product Portfolio
- 8.2.5 PCAS Recent Developments
- 8.3 Mitsui Chemicals
- 8.3.1 Mitsui Chemicals Company Information
- 8.3.2 Mitsui Chemicals Business Overview
- 8.3.3 Mitsui Chemicals Biodegradable Medical Polymer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Mitsui Chemicals Biodegradable Medical Polymer Product Portfolio
- 8.3.5 Mitsui Chemicals Recent Developments
- 8.4 KLS Martin
- 8.4.1 KLS Martin Company Information
- 8.4.2 KLS Martin Business Overview
- 8.4.3 KLS Martin Biodegradable Medical Polymer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 KLS Martin Biodegradable Medical Polymer Product Portfolio
- 8.4.5 KLS Martin Recent Developments
- 8.5 Evonik
- 8.5.1 Evonik Company Information
- 8.5.2 Evonik Business Overview
- 8.5.3 Evonik Biodegradable Medical Polymer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Evonik Biodegradable Medical Polymer Product Portfolio
- 8.5.5 Evonik Recent Developments
- 8.6 DSM
- 8.6.1 DSM Company Information
- 8.6.2 DSM Business Overview
- 8.6.3 DSM Biodegradable Medical Polymer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 DSM Biodegradable Medical Polymer Product Portfolio
- 8.6.5 DSM Recent Developments
- 8.7 Corbion
- 8.7.1 Corbion Company Information
- 8.7.2 Corbion Business Overview
- 8.7.3 Corbion Biodegradable Medical Polymer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Corbion Biodegradable Medical Polymer Product Portfolio
- 8.7.5 Corbion Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Biodegradable Medical Polymer Value Chain Analysis
- 9.1.1 Biodegradable Medical Polymer Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Biodegradable Medical Polymer Production Mode & Process
- 9.2 Biodegradable Medical Polymer Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Biodegradable Medical Polymer Distributors
- 9.2.3 Biodegradable Medical Polymer Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst